Last reviewed · How we verify

NCT05867459

Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate

Status unknown Last updated 22 May 2023
What this trial tests

trial testing Serum creatinine in CKD PREGNANT WOMEN in 30 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 April 2023
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 18 to 52, female only, with CKD PREGNANT WOMEN. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the work: In this study, we aimed: Is to investigate the following issues: (1) the pregnancy outcomes of patients with CKD (2) additional risk factors for adverse pregnancy outcomes in patients with CKD in the area of sohag governorate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Serum creatinine

Trials testing the same drug.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05867459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing